revolade
novartis europharm limited - eltrombopag - purpura, trombocitopenija, idiopatinė - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ir 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ir 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
gattart
alkaloid - int d.o.o. - kalcio karbonatas/magnio subkarbonatas, sunkusis - kramtomosios tabletės - 680 mg/80 mg - ordinary salt combinations
mavenclad
merck europe b.v. - cladribine - išsėtinė sklerozė - imunosupresantai - suaugusių pacientų su labai aktyvaus recidyvuojančia išsėtine skleroze (is) nustatytus klinikinių ar vizualizavimo įranga.
berocca plus
bayer, uab - askorbo rūgštis/tiamino hidrochloridas/riboflavinas/nikotinamidas/pantoteno rūgštis/piridoksino hidrochloridas/cianokobalaminas/folio rūgštis hidratas/biotinas/kalcio karbonatas/magnio subkarbonatas/magnio sulfatas/cinko citratas - šnypščiosios tabletės - 500 mg/15 mg/15 mg/50 mg/23 mg/10 mg/0,01 mg/0,4 mg/0,15 mg/244 mg/195 mg/328 mg/32 mg - vitamin b-complex with vitamin c;vitamin b-complex with minerals
maalox
sanofi-aventis lietuva, uab - magnio hidroksidas/aliuminio hidroksidas - kramtomosios tabletės - 460 mg/400 mg/4,3 ml; 40 mg/35 mg/ml; 400 mg/400 mg - ordinary salt combinations
rennie
bayer, uab - kalcio karbonatas/magnio karbonatas - kramtomosios tabletės - 680 mg/80 mg - antacids, other combinations
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - virškinimo trakto stromos navikai - antinavikiniai vaistai - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
rennie orange
bayer, uab - kalcio karbonatas/magnio subkarbonatas, sunkusis - kramtomosios tabletės - 680 mg/80 mg - ordinary salt combinations
olysio
janssen-cilag international nv - simeprevir - hepatitas c, lėtinis - antivirusiniai vaistai sisteminiam naudojimui - olysio skiriamas kartu su kitais vaistiniais preparatais, skirtais suaugusiems pacientams gydyti lėtinį hepatitą c (chc). hepatito c viruso (hcv) genotipo konkrečios veiklos,.
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antinavikiniai vaistai - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.